Sign up Australia
Proactive Investors - Run By Investors For Investors

Pressure BioSciences Inc looks ahead to technology showcase at Boston proteome conference

The group’s ‘cell opening’ technology will be showcased as part of a workshop at the US Human Proteome Organization (US HUPO) annual conference in Boston next month.
Pressure BioSciences Inc looks ahead to technology showcase at Boston proteome conference
Next-generation solutions can industrialise enable life science research, PBIO says.

Pressure Bioscience (OTCMKTS:PBIO) told investors that its ‘cell opening’ technology will be showcased at an upcoming conference focussing on  proteomes.

The company’s partner SCIEX, a life science analytics specialist, is presenting and leading a workshop at the annual US Human Proteome Organization (US HUPO) conference in Boston between March 13 and 16.

Representatives of SCIEX, Pressure Bioscience and gene and protein analysis specialist Advaita Bioinformatics will share examples of how next-generation solutions can enable life science researchers to unlock the potential of their discoveries, the company said in a statement.

It highlighted that examples presented via the workshop will show how SCIEX's next-generation mass spectrometry-based solutions - combined with PBI's PCT platform and Advaita's iPathwayGuide - can industrialize research workflows.

Pressure Bioscience senior scientist Vera Gross will, as part of the showcase, give a presentation discussing the on advances of quantitative SWATH-MS technology with the introduction of new PCT-based sample preparation techniques.

View full PBIO profile View Profile

Pressure BioSciences Inc Timeline

Related Articles

picture of addict
November 16 2017
To build the UK's first £1bn, self-sustainable biotech is the aim for chief executive Clive Dix
1527682514_angel-delight.jpg
May 30 2018
The latest fundraiser underscores the fact the life sciences business is well supported in the City
1511901712_biotech_517925923.jpg
November 29 2017
The company has developed a "unique and superior pressure" cycling technology (PCT), says Zacks.

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use